Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: Their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies
Keywords: Cu(II) and diorganotin(IV) enantiomeric complexes; Preliminary DNA binding studies; Cleavage activity; Cytotoxicity activity; SRB assay